Pioneering Gene Writing™—a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source

Developing first-in-class gene therapies, Anellovector™ therapies, using a novel viral vector platform based on its groundbreaking work on the human commensal virome

Developing CD8 T cell immune modulators for the treatment of autoimmune diseases